The global probiotic ingredients market
size is projected to reach USD 3.56 billion by 2025, according to a new
report by Grand View Research, Inc. It is expected to expand at a CAGR
of 7.9% over the forecast period. Increasing consumer awareness
regarding preventive healthcare has emerged as a key market driver.
Probiotics play a great role in preventive healthcare as they prevent
the occurrence of a disease by strengthening the immune system of the
body.
Another significant factor bolstering the product demand
across the globe is the increasing investments by key market players in
R&D activities with respect to the development of efficient
probiotic strains. There have been advancements in the delivery systems
used for delivering probiotics in the human body. Efficient strains have
been developed that work in compatibility with these delivery systems.
This allows a high number of probiotics to reach the body parts such as
the intestines, thus increasing their effectiveness.
Companies have developed and identified proprietary strains
for specific applications. These strains meet different requirements
possessed by different medical conditions. Lactobacillus fermentum
VRI-003 PCC and Lactobacillus rhamnosus HN001 are used to cure Eczema.
Lactobacillus acidophilus NCFM and Bifidobacterium animalis lactis Bi-07
strains are used to cure cold. Lactobacillus acidophilus, Lactobacillus
reuteri RC-14, and Lactobacillus rhamnosus GR-1 are effective for
treating vaginal infection.
Europe emerged as the largest probiotic ingredients market
in 2018, with a revenue of USD 742.2 million. Rising awareness
concerning gut and immune health, prevalence of gut-related diseases,
and the presence of geriatric population are some of the key factors
contributing significantly to the regional market growth. Increasing
consumption of animal probiotic ingredients is anticipated to further
fuel the regional expansion. Increasing focus on mortality reduction and
growth of animals coupled with the need for feed conversion efficiency
is expected to trigger the regional demand.
The market participants have been engaging in mergers and
acquisitions in a bid to increase their market share. For instance, in
December 2017, Royal DSM, a science-based company headquartered in
Netherlands announced the acquisition of Biocare Copenhagen A/S, a
Denmark-based food supplements manufacturing and supplying company. The
acquisition was intended to expand the former’s product offerings of
probiotic gut health ingredients.
To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/probiotic-ingredients-market
Further key findings from the report suggest:
-
In terms of ingredient, bacteria emerged as the largest segment with a
revenue of USD 1.74 billion in 2018. The segment is expected to
continue its dominance over the forecast period
-
In terms of application, probiotic dietary supplements segment is
anticipated to expand at the fastest CAGR of 8.2% over the forecast
period, attributable to the increasing demand for these supplements from
various industries including pharmaceutical, nutraceutical, and
functional supplements
-
In terms of end use, human probiotics segment is expected to lead the
market over the forecast period, with animal probiotics segment at a
distant second. Advancement in oral probiotic market has contributed to
the growth of the human probiotics segment
-
Asia Pacific is anticipated to witness the fastest CAGR of 8.4% over
the forecast period. Led by countries such as India, China, and Japan,
the Asia Pacific probiotic ingredients market is driven by the
increasing adoption of the product predominantly in infant formula
-
The market is highly competitive with a sizable number of domestic
and international players sharing the market space. Product innovation
and mergers and acquisitions are among the key strategies deployed by
prominent players to withstand competition
-
The key market participants are Ganeden, Inc.; Probiotical S.p.A.;
Biocodex, Inc.; Sabinsa Corporation; BioGaia AB; Chr. Hansen Holding
A/S; and Lallemand, Inc. among others
Grand View Research has segmented the global probiotic
ingredients market on the basis of ingredient, application, end use,
form, and region:
Probiotic Ingredient Outlook (Revenue, USD Million, 2014 - 2025)
-
Bacteria
-
Lactobacilli
-
Bifidobacterum
-
Streptococcus
-
Other Genus
-
Lactobacilli
-
Yeast
-
Spore Formers
Probiotic Ingredients Application Outlook (Revenue, USD Million, 2014 - 2025)
-
Probiotic Food & Beverages
-
Probiotic Dietary Supplements
-
Animal Feed Probiotic
Probiotic Ingredients End Use Outlook (Revenue, USD Million, 2014 - 2025)
-
Human Probiotics
- Animal Probiotics
Probiotic Ingredients Form Outlook (Revenue, USD Million, 2014 - 2025)
-
Dry Form
-
Liquid Form
